113 related articles for article (PubMed ID: 2110866)
1. Syntheses and biological activities of renin inhibitors containing statine analogues.
Nishi T; Saito F; Nagahori H; Kataoka M; Morisawa Y; Yabe Y; Sakurai M; Higashida S; Shoji M; Matsushita Y
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):103-9. PubMed ID: 2110866
[TBL] [Abstract][Full Text] [Related]
2. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of some transition-state inhibitors of human renin.
Bühlmayer P; Caselli A; Fuhrer W; Göschke R; Rasetti V; Rüeger H; Stanton JL; Criscione L; Wood JM
J Med Chem; 1988 Sep; 31(9):1839-46. PubMed ID: 3137345
[TBL] [Abstract][Full Text] [Related]
4. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives.
Bradbury RH; Major JS; Oldham AA; Rivett JE; Roberts DA; Slater AM; Timms D; Waterson D
J Med Chem; 1990 Sep; 33(9):2335-42. PubMed ID: 2118184
[TBL] [Abstract][Full Text] [Related]
5. Statine-containing dipeptide and tripeptide inhibitors of human renin.
Kokubu T; Hiwada K; Nagae A; Murakami E; Morisawa Y; Yabe Y; Koike H; Iijima Y
Hypertension; 1986 Jun; 8(6 Pt 2):II1-5. PubMed ID: 3087874
[TBL] [Abstract][Full Text] [Related]
6. ES-8891, an orally active inhibitor of human renin.
Kokubu T; Hiwada K; Murakami E; Muneta S; Kitami Y; Salmon PF
Hypertension; 1990 Jun; 15(6 Pt 2):909-13. PubMed ID: 2112512
[TBL] [Abstract][Full Text] [Related]
7. New renin inhibitors containing novel analogues of statine.
Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
[TBL] [Abstract][Full Text] [Related]
8. Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.
Hui KY; Carlson WD; Bernatowicz MS; Haber E
J Med Chem; 1987 Aug; 30(8):1287-95. PubMed ID: 3302256
[TBL] [Abstract][Full Text] [Related]
9. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 1. Synthesis and biological properties of alkyl alcohol and statine derivatives.
Roberts DA; Bradbury RH; Brown D; Faull A; Griffiths D; Major JS; Oldham AA; Pearce RJ; Ratcliffe AH; Revill J
J Med Chem; 1990 Sep; 33(9):2326-34. PubMed ID: 2118183
[TBL] [Abstract][Full Text] [Related]
10. Novel renin inhibitors containing the amino acid statine.
Boger J; Lohr NS; Ulm EH; Poe M; Blaine EH; Fanelli GM; Lin TY; Payne LS; Schorn TW; LaMont BI; Vassil TC; Stabilito II; Veber DF; Rich DH; Bopari AS
Nature; 1983 May 5-11; 303(5912):81-4. PubMed ID: 6341856
[TBL] [Abstract][Full Text] [Related]
11. [In vitro and in vivo inhibition of renin by a thiazolylalanyl cyclostatine derivative].
Muneta S
Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):865. PubMed ID: 2512401
[TBL] [Abstract][Full Text] [Related]
12. Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.
Rosenberg SH; Plattner JJ; Woods KW; Stein HH; Marcotte PA; Cohen J; Perun TJ
J Med Chem; 1987 Jul; 30(7):1224-8. PubMed ID: 3298652
[TBL] [Abstract][Full Text] [Related]
13. Design of rat renin inhibitory peptides.
Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E
J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320
[TBL] [Abstract][Full Text] [Related]
14. Renin inhibitors. II. Synthesis and structure-activity relationships of N-terminus modified inhibitors containing a homostatine analogue.
Atsuumi S; Nakano M; Koike Y; Tanaka S; Funabashi H; Matsuyama K; Nakano M; Sawasaki Y; Funabashi K; Morishima H
Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3214-21. PubMed ID: 1294323
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel. (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid.
Thaisrivongs S; Pals DT; Kroll LT; Turner SR; Han FS
J Med Chem; 1987 Jun; 30(6):976-82. PubMed ID: 3295239
[TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of human renin by statine-containing tripeptide renin inhibitor (ES-1005).
Kokubu T; Hiwada K; Murakami E; Muneta S; Morisawa Y; Yabe Y; Koike H; Iijima Y
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S88-90. PubMed ID: 2485069
[TBL] [Abstract][Full Text] [Related]
17. A highly potent and long-acting oral inhibitor of human renin.
Hiwada K; Kokubu T; Murakami E; Muneta S; Morisawa Y; Yabe Y; Koike H; Iijima Y
Hypertension; 1988 Jun; 11(6 Pt 2):708-12. PubMed ID: 3134306
[TBL] [Abstract][Full Text] [Related]
18. Design of potent substrate-analogue inhibitors of canine renin.
Hui KY; Siragy HM; Haber E
Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma renin during renin inhibition. Studies with a novel immunoassay.
Hofbauer KG; Wood JM; Gulati N; Heusser C; Ménard J
Hypertension; 1985; 7(3 Pt 2):I61-5. PubMed ID: 2987126
[TBL] [Abstract][Full Text] [Related]
20. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
